ACLARIS THERAPEUTICS INC
- Country
- 🇮🇳India
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 101
- Market Cap
- $84.9M
- Website
- http://www.aclaristx.com
A Study of A-101 Topical Solution for the Treatment of Common Warts
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2020-10-27
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 502
- Registration Number
- NCT03691831
- Locations
- 🇺🇸
Aclaris Investigational Site, Norfolk, Virginia, United States
Study of A-101 Topical Solution for the Treatment of Common Warts
- First Posted Date
- 2018-09-27
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 503
- Registration Number
- NCT03687372
- Locations
- 🇺🇸
Aclaris Investigational site, San Diego, California, United States
🇺🇸Aclaris Investigational Site, Spokane, Washington, United States
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
- Conditions
- Interventions
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 87
- Registration Number
- NCT03594227
- Locations
- 🇺🇸
Aclaris Investigational Site, Austin, Texas, United States
🇺🇸Aclaris Investigator Site, Norfolk, Virginia, United States
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03585296
- Locations
- 🇺🇸
Aclaris Investigator Site, Austin, Texas, United States
🇺🇸Aclaris Investigational Site, Portland, Oregon, United States
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
- Conditions
- Interventions
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2019-12-11
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT03551821
- Locations
- 🇺🇸
Aclaris Investigator Site, Boynton Beach, Florida, United States
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT03495817
- Locations
- 🇺🇸
Aclaris Investigational Site, Austin, Texas, United States
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT03487588
- Locations
- 🇺🇸
Aclaris Investigational Site, Austin, Texas, United States
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
- First Posted Date
- 2018-03-19
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT03468855
- Locations
- 🇺🇸
Aclaris Investigator Site, Lynchburg, Virginia, United States
Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
- Conditions
- Interventions
- First Posted Date
- 2017-12-21
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT03380390
- Locations
- 🇺🇸
Center for Dermatology and Laser Surgery, Sacramento, California, United States
🇺🇸Laser & Skin Surgery Center of New York Professional Corporation, New York, New York, United States
🇺🇸Skin Laser and Surgery Specialists of NY/NJ, Hackensack, New Jersey, United States
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
- Conditions
- Interventions
- First Posted Date
- 2017-11-28
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Aclaris Therapeutics, Inc.
- Target Recruit Count
- 129
- Registration Number
- NCT03354637
- Locations
- 🇺🇸
Aclaris Investigator Site, San Antonio, Texas, United States